Holen Sie sich die Stockscreener-App
0.8815
1.32%
0.0115
Schlusskurs vom Vortag:
$0.87
Offen:
$0.87
24-Stunden-Volumen:
4,011
Relative Volume:
1.86
Marktkapitalisierung:
$N/A
Einnahmen:
$52.16M
Nettoeinkommen (Verlust:
$-48.60M
KGV:
-0.2041
EPS:
-4.32
Netto-Cashflow:
$-77.48M
1W Leistung:
-0.60%
1M Leistung:
+2.50%
6M Leistung:
-56.03%
1J Leistung:
-82.58%
1-Tages-Spanne:
$0.87
$0.8815
1-Wochen-Bereich:
$0.863
$0.8861
52-Wochen-Spanne:
$0.86
$0.9495
Hookipa Pharma Inc Stock (HOOK) Company Profile
Firmenname
Hookipa Pharma Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HOOK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
0.8815 | 0 | 52.16M | -48.60M | -77.48M | -4.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-15 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-12-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-03 | Eingeleitet | Truist | Buy |
| 2020-10-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-09-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-05-13 | Eingeleitet | BofA/Merrill | Buy |
| 2019-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Hookipa Pharma Inc Aktie (HOOK) Neueste Nachrichten
Aug Sentiment: Why HOOKIPA Pharma Inc stock remains resilientJuly 2025 PostEarnings & Growth Focused Stock Reports - moha.gov.vn
Is HOOKIPA Pharma Inc. stock trading at a premium valuationInsider Buying & Reliable Breakout Forecasts - Newser
Why HOOKIPA Pharma Inc. stock is trending among retail tradersPortfolio Update Summary & AI Powered Trade Plan Recommendations - Newser
Gilead to buy certain Hookipa Pharma assets for up to $10M - MSN
HOOKIPA Pharma Inc Stock Analysis and ForecastMarket Volatility Update & Hedge Fund-Style Analysis Now Free - earlytimes.in
What drives HOOKIPA Pharma Inc stock priceVolume Weighted Average Price & Affordable Trading Strategies - earlytimes.in
Is HOOKIPA Pharma Inc. stock supported by strong cash flowsEarnings Beat & Target Return Focused Stock Picks - newser.com
Can HOOKIPA Pharma Inc. stock reach $100 price targetTrade Volume Report & Verified Entry Point Signals - newser.com
Why HOOKIPA Pharma Inc. stock appeals to dividend seekersMarket Volume Report & Safe Swing Trade Setups - newser.com
Will HOOKIPA Pharma Inc. stock deliver strong dividend growth2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
Forecasting HOOKIPA Pharma Inc. price range with options dataWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com
How HOOKIPA Pharma Inc. stock reacts to oil pricesWeekly Gains Report & Real-Time Market Sentiment Alerts - newser.com
Is HOOKIPA Pharma Inc. stock a good choice for value investorsLong Setup & Community Trade Idea Sharing - newser.com
Evaluating HOOKIPA Pharma Inc. with trendline analysisQuarterly Trade Summary & Step-by-Step Trade Execution Guides - newser.com
Why HOOKIPA Pharma Inc. stock is favored by pension funds2025 Key Highlights & Community Verified Trade Alerts - newser.com
HOOKIPA Pharma Inc. stock trendline breakdownJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
Using Python tools to backtest HOOKIPA Pharma Inc. strategiesJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com
Why HOOKIPA Pharma Inc. stock is considered a top pickJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Can HOOKIPA Pharma Inc. stock sustain market leadershipQuarterly Performance Summary & Accurate Technical Buy Alerts - newser.com
Finanzdaten der Hookipa Pharma Inc-Aktie (HOOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
1.05%
Kapitalisierung:
|
Volumen (24h):